M281, an Anti-FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first-in-human study
341,346 The recruitment and oligomerization of caspase-1 by this complex initiate the activation and proteolytic cleavage of its substrates
C.HwangD
Edited by Boris Zhivotovsky Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
And maybe here is a good place to spell out just how long the development and approval process for these drugs can be
NaBPC157 unlike morphine, had no effect on normal animals